Generic Name: trabectedin (tra BEK te din)
Brand Name: Yondelis
What is trabectedin?
Trabectedin is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Trabectedin is used to treat liposarcoma, a rare type of cancer that grows in fatty tissues of the body.
Trabectedin is also used to treat leiomyosarcoma, a rare fast-growing type of cancer that grows in many tissues of the body, including fat, muscle, bone, joints, and blood vessels.
Trabectedin is used to treat cancer that has spread to other parts of the body or cannot be treated with surgery.
Trabectedin may also be used for purposes not listed in this medication guide.
Serious and sometimes fatal infections may occur during treatment with trabectedin. Call your doctor at once if you have signs of infection such as fever, chills, flu symptoms, pale skin, or easy bruising or bleeding.
Before taking this medicine
You should not be treated with trabectedin if you are allergic to it.
To make sure trabectedin is safe for you, tell your doctor if you have:
Trabectedin can harm an unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine, whether you are a man or a woman. Trabectedin use by either parent may harm the unborn baby.
If you are a woman, keep using birth control for at least 2 months after your last dose of trabectedin. If you are a man, keep using birth control for at least 5 months after your last dose. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using trabectedin.
It is not known whether trabectedin passes into breast milk or if it could affect the nursing baby. Tell your doctor if you are breast-feeding.
How is trabectedin given?
Trabectedin is injected into a vein through a central line IV. A healthcare provider will give you this injection.
Before you receive a dose of trabectedin, you may need a blood test to check your liver function.
Trabectedin must be given slowly and the infusion can take up to 24 hours to complete.
Trabectedin is usually given once every 3 weeks. Your doctor will determine how long to treat you with trabectedin.
You may be given steroid medication to prevent certain side effects of trabectedin.
Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when trabectedin is injected.
Trabectedin can lower blood cells that help your body fight infections and help your blood to clot. Serious and sometimes fatal infections may occur during treatment with trabectedin. Your blood will need to be tested often.
Your heart function may need to be checked using an electrocardiograph or ECG (sometimes called an EKG).
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment for your trabectedin injection.
What happens if I overdose?
Since this medicine is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.
What should I avoid while receiving trabectedin?
Trabectedin side effects
A rare but serious side effect of trabectedin is called capillary leak syndrome. Call your doctor right away if you have signs of this condition, which may include: weakness or tired feeling, nausea, sudden dizziness or light-headed feeling, and sudden swelling in your arms, legs and other parts of the body.
Call your doctor at once if you have:
pain, burning, irritation, or skin changes where the injection was given;
heart problems--chest pain, fast or pounding heartbeats, shortness of breath (even with mild exertion), swelling, rapid weight gain;
breakdown of muscle tissue--unexplained muscle pain, tenderness, or weakness (especially if you also have fever, unusual tiredness, and dark colored urine);
liver problems--nausea, upper stomach pain, confusion, tiredness, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or
low blood cell counts--fever, chills, flu-like symptoms, swollen gums, mouth sores, skin sores, rapid heart rate, pale skin, easy bruising, unusual bleeding, feeling tired or light-headed.
Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.
Common side effects may include:
nausea, vomiting, loss of appetite;
low blood cell counts;
abnormal liver or kidney function tests;
feeling short of breath.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
Trabectedin dosing information
Usual Adult Dose for Soft Tissue Sarcoma:
-Normal Bilirubin and AST or ALT 2.5 Times the Upper Limit of Normal (ULN) or Less:
1.5 mg/m2 via IV infusion every 21 days (3 weeks)
-Serum Bilirubin Levels Above Institutional ULN:
No recommended dose.
Duration of Therapy: Until disease progression or unacceptable toxicity
-Administer this drug over 24 hours through a central venous line using an infusion set with a 0.2 micron polyethersulfone (PES) in-line filter.
-Complete infusion within 30 hours of drug reconstitution.
-Administer dexamethasone 20 mg IV 30 minutes prior to each dose.
Use: Treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.
What other drugs will affect trabectedin?
Many drugs can interact with trabectedin. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide. Tell your doctor about all medicines you use, and those you start or stop using during your treatment with trabectedin. Give a list of all your medicines to any healthcare provider who treats you.
More about trabectedin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: alkylating agents
Other brands: Yondelis
Related treatment guides
Where can I get more information?
- Your doctor or pharmacist can provide more information about trabectedin.
- Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
- Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2012 Cerner Multum, Inc. Version: 1.04.
Date modified: January 03, 2018
Last reviewed: July 28, 2017